BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12483364)

  • 1. Bilateral adrenal swelling as a cause of chest, back, and upper abdominal pain in essential thrombocythemia and polycythemia vera is due to microvascular ischemic thrombosis rather than to hemorrhage.
    Michiels JJ; Berneman Z; Schroyens W; Krestin GP
    Ann Hematol; 2002 Dec; 81(12):691-4. PubMed ID: 12483364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.
    Michiels JJ; Berneman ZN; Schroyens W; Van Vliet HH
    Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What vascular events suggest a myeloproliferative disorder?].
    Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U
    J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe chest and back pain and bilateral massive adrenal swelling in polycythemia vera: an uncommon case after esophagectomy.
    Fernández AB; De Avila AS; Gómez N
    Minerva Anestesiol; 2012 Dec; 78(12):1416-7. PubMed ID: 22643542
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
    Randi ML; Fabris F; Ruzzon E; Pacquola E; Cella G; Girolami A
    Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia.
    Cucuianu A; Stoia M; Farcaş A; Dima D; Zdrenghea M; Paţiu M; Olinic D; Petrov L
    Rom J Intern Med; 2006; 44(4):397-406. PubMed ID: 18386616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; van Vliet HH
    Blood Cells Mol Dis; 2006; 36(2):199-205. PubMed ID: 16510297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
    Landolfi R; Cipriani MC; Novarese L
    Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils.
    Falanga A; Marchetti M; Barbui T; Smith CW
    Semin Hematol; 2005 Oct; 42(4):239-47. PubMed ID: 16210037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
    Landolfi R; Di Gennaro L; Novarese L; Patrono C
    Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera.
    van Genderen PJ; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):357-63. PubMed ID: 9263352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral adrenal hemorrhagic infarction in essential thrombocythemia.
    Burnet G; Lambert M; Annet L; Lefebvre C
    Acta Clin Belg; 2015 Dec; 70(6):461-2. PubMed ID: 26133054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk.
    Barbui T; Finazzi G
    Semin Thromb Hemost; 2007 Jun; 33(4):321-9. PubMed ID: 17525889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study.
    Gisslinger H; Müllner M; Pabinger I; Heis-Vahidi-Fard N; Gisslinger B; Brichta A; Bachleitner-Hofmann T; Mannhalter C
    Haematologica; 2005 Mar; 90(3):408-10. PubMed ID: 15749677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.
    Passamonti F; Rumi E; Pungolino E; Malabarba L; Bertazzoni P; Valentini M; Orlandi E; Arcaini L; Brusamolino E; Pascutto C; Cazzola M; Morra E; Lazzarino M
    Am J Med; 2004 Nov; 117(10):755-61. PubMed ID: 15541325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.